Researchers have shown exactly how the anaesthetic ketamine helps depression with images that show the orbitofrontal cortex – the part of the brain that is overactive in depression – being ‘switched off’.
Ketamine, an anaesthetic that is popular with doctors on the battlefield and also with vets because it allows a degree of awareness without pain, is a new hope for the treatment of depression – but the minute-by-minute images produced by Professor Bill Deakin and his team show how the drug achieves this in an unexpected way.
The drug deactivates the orbitofrontal cortex – located above the eyes, in the centre – which is thought to give rise to highly emotional thoughts such as guilt and feelings of worthlessness and causes reactions in visceral body parts such as a churning stomach and a racing heart.
Professor Deakin, of the Faculty of Medical and Human Sciences, said: “We were surprised to see it working on that part of the brain. We expected to see it work on the parts that control psychosis, at the sides of the brain. There was some activity there but more striking was the switching off of the depression centre.”
The study, published in the Archives of General Psychiatry, sought to identify the sites of action of ketamine but also the release of glutamate turned out to be important in ketamine’s effects and this could point to new quick treatments to get people out of severe or long-standing depression.
The team at the University’s Neuroscience and Psychiatry Unit (NPU) and Imaging Science and Biomedical Engineering (ISBE) gave intravenous ketamine to 33 healthy male, right-handed volunteers at the Wellcome Trust Clinical Research Facility (WTCRF). Scans showed activity in the orbitofrontal cortex stopped immediately.
In studies in the US, depressed people found that their symptoms begin to improve 24 hours after taking ketamine and continued to improve for two days after that. Professor Deakin is now funded to develop this approach to treatment in psychiatric patients in the new £30M Biomedical Research Centre awarded to Central Manchester and Manchester Children’s Hospital NHS Trust just last month. He hopes to develop a treatment within the next five years.
He said: “The study results have given us a completely novel way of treating depression and a new avenue of understanding depression.”
Professor Helen Mayberg, at Emory University in the United States, who pioneered deep brain stimulation to stop overactivity of the orbitofrontal cortex, in which electrodes are used during brain surgery, agreed: “This is a terrific finding...of extreme interest to our ongoing deep brain stimulation studies.”
Source: University of Manchester
Related stories:
Parental instinct found in the brain
A possible basis for parental instinct has been found in the brain, according to a team led by Oxford University scientists.
Brain activity linked to the parental instinct
Why do we almost instinctively treat babies as special, protecting them and enabling them to survive? Darwin originally pointed out that there is something about infants which prompts adults to respond to and care for them which allows our species to survive. Nobel-Prize-winning zoologist Konrad Lorenz proposed that it is the specific structure of the infant face, including a relatively large head and forehead, large and low lying eyes and bulging cheek region, that serves to elicit these parental responses. But the biological basis for this has remained elusive.
Location, location, location!
It's a classic upper middle class dilemma: Should we buy a perfect second home in a place that takes hours to get to, or should we settle for something closer but not as nice? In the rodent world, an equivalent decision-making situation might be, "Was the food I liked better down this alley or over there?"
Breakthrough in cell-type analysis offers new ways to study development and disease
(PhysOrg.com) -- Like skilled assassins, many diseases seem to know exactly what types of cells to attack. While decimating one cadre of cells, diseases will inexplicably spare a seemingly identical group of neighbors. What makes cells vulnerable or not depends largely on the kinds and amounts of proteins they produce — their “translational profile,” in the lingo of molecular biology. For this reason, scientists have struggled to parse the subtle molecular differences among the hundreds of specialized cell types that are tangled together in tissues like the brain.
Breakthrough in cell-type analysis offers new ways to study development and disease
Like skilled assassins, many diseases seem to know exactly what types of cells to attack. While decimating one cadre of cells, diseases will inexplicably spare a seemingly identical group of neighbors. What makes cells vulnerable or not depends largely on the kinds and amounts of proteins they produce - their "translational profile," in the lingo of molecular biology. For this reason, scientists have struggled to parse the subtle molecular differences among the hundreds of specialized cell types that are tangled together in tissues like the brain.
Study: Brain stimulation may ease anxiety disorder
(AP) -- The same kind of deep brain stimulation used to treat some patients for Parkinson's disease also helped a few people suffering from obsessive-compulsive disorder, French scientists reported.
Light triggers a new code for brain cells
Brain cells can adopt a new chemical code in response to cues from the outside world, scientists working with tadpoles at the University of California, San Diego report in the journal
Nature this week.
Babies placed in incubators decrease risk of depression as adults
Babies who receive incubator care after birth are two to three times less likely to suffer depression as adults according to a new study published in the journal
Pyschiatry Research. The surprising discovery was made by scientists from the Université de Montréal and Sainte Justine Hospital Research Center in collaboration with researchers from McGill University, the Douglas Hospital Research Centre and the Institute of Psychiatry at King's College in the U.K.